Cathepsin D exon 2 polymorphism associated with general intelligence in a healthy older population

Molecular Psychiatry

Volumn 8, Issue 1, 2003, Pages 14-18

  Payton, A ^a   Holland, F ^b   Diggle, P ^c   Rabbitt, P ^a   Horan, M ^a   Davidson, Y ^a   Gibbons, L ^a   Worthington, J ^a   Ollier, W E R ^a   Pendleton, N ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

Association; Cathepsin D; Cognitive decline; Intelligence; Polymorphism

Indexed keywords

CATHEPSIN D; SOMATOMEDIN B RECEPTOR;

ADULT; AGED; AMINO ACID SUBSTITUTION; COGNITIVE DEFECT; DEMENTIA; EXON; FEMALE; GENE LOCATION; GENETIC POLYMORPHISM; HERITABILITY; HOMEOBOX; HUMAN; HUMAN EXPERIMENT; INTELLIGENCE; LYSOSOME; MALE; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; REVIEW; RISK FACTOR; TRANS GOLGI NETWORK;

AGED; AGED, 80 AND OVER; AGING; CATHEPSIN D; COGNITION; COGNITION DISORDERS; EXONS; FEMALE; GENOTYPE; HUMANS; INTELLIGENCE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 12244267952     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001239     Document Type: Review

References (27)

1. Bouchard Jr TJ, McGue M. Familial studies of intelligence: a review. Science 1981; 212: 1055-1059.
2. Schmand B, Smit JH, Geerlings MI, Lindeboom J. The effects of intelligence and education on the development of dementia. A test of the brain reserve hypothesis. Psychol Med 1997; 27: 1337-1344.
3. Evans DA, Beckett LA, Albert MS, Hebert LE, Scherr PA, Funkenstein HH et al. Level of education and change in cognitive function in a community population of older persons. Ann Epidemiol 1993; 3: 71-77.
4. MRC CFAS and RIS MRC CFAS. Profile of disability in elderly people: estimates from a longitudinal population study. B M J 1999; 318: 1108-1111.
5. Pendleton N, Payton A, van den Boogerd EH, Holland F, Diggle P, Rabbitt PM et al. Apolipoprotein E genotype does not predict decline in intelligence in healthy older adults. Neurosci Lett 2002; 324: 74-76.
6. Chorney MJ, Chorney K, Seese N, Owen MJ, Daniels J, McGuffin P et al. A quantitative trait locus associated with cognitive ability in children. Psychol Sci 1998; 9: 159-166.
7. Fisher PJ, Turic D, Williams NM, McGuffin P, Asherson P, Ball D et al. DNA pooling identifies QTLs on chromosome 4 for general cognitive ability in children. Hum Mol Genet 1999; 8: 915-922.
8. Touitou I, Capony F, Brouillet JP, Rochefort H. Missense polymorphism (C/T224) in the human cathepsin D pro-fragment determined by polymerase chain reaction - single strand conformational polymorphism analysis and possible consequences in cancer cells. Eur J Cancer 1994; 30A: 390-394.
9. Papassotiropoulos A, Bagli M, Feder O, Jessen F, Maier W, Rao ML et al. Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease. Neurosci Lett 1999; 262: 171-174.
10. Papassotiropoulos A, Bagli M, Kurz A, Kornhuber J, Forstl H, Maier W et al. A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease. Ann Neurol 2000; 47: 399-403.
11. Crawford FC, Freeman MJ, Schinka J, Abdullah LI, Richards D, Sevush S et al. The genetic association between cathepsin D and Alzheimers disease. Neurosci Lett 2000; 289: 61-65.
12. McIlroy SP, Dynan KB, McGleenon BM, Lawson JT, Passmore AP. Cathepsin D gene exon 2 polymorphism and sporadic Alzheimer's disease. Neuro Sci Lett 1999; 273: 140-141.
13. Bhojak TJ, DeKosky ST, Ganguli M, Kamboh M. Genetic polymorphisms in the cathepsin D and interleukin-6 genes and the risk of Alzheimer's disease. Neurosci Lett 2000; 288: 21-24.
14. Mateo I, Sanchez-Guerra M, Combarros O, Llorca J, Infante J, Gonzalez-Garcia J et al. Lack of association between cathepsin D and Alzheimer disease in a Spanish sample. Am J Med Gen 2002; 114: 31-33.
15. Bertram L, Blacker D, Crystal A, Mullin K, Keeney D, Jones J et al. Candidate genes showing no evidence for association or linkage with Alzheimer's disease using family-based methodologies. Exp Geron 2000; 35: 1353-1361.
16. Roberts LR, Adjei PN, Gores GJ. Cathepsins as effector proteases in hepatocytes apoptosis. Cell Biochem Biophys 1999; 30: 71-88.
17. Ollinger K. Inhibition of cathepsin D prevents free-radical-induced apoptosis in rat cardiomyocytes. Arch Biochem Biophys 2000; 373: 346-351.
18. Tyynela J, Sohar I, Sleat S, Rosalie MG, Donnelly RJ, Baumann M et al. A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration. EMBOJ 2000; 19: 2786-2792.
19. Rabbit P, Donlan C, Bent N, McInnes L, Abson V. The University of Manchester Age and Cognitive Performance Research Centre and North East Age Research Longitudinal Programmes, 1982 to 1997. Z Gerontol 1993; 26: 176-183.
20. Heim AW. The AH 4 Group of Intelligence Tests. NFER-Nelson: Windsor, 1971.
21. Standard Occupational Classification. Vol. 3, HMSO: London, 1991.
22. Shibata M, Kanamori S, Ishara K, Ohsawa Y, Konishi A, Kametaka S et al. Participation of cathepsins B and D in apoptosis of PC12 cells following serum deprivation. Biochem Biophys Res Commun 1998; 251: 199-203.
23. Ishara K, Ohsawa Y, Kanamori S, Shibata M, Waguri S, Sato N et al. Regulation of a novel pathway for cell death by lysosomal aspartic and cysteine proteinases. Neuroscience 1999; 91: 233-249.
24. Lorenzo K, Ton P, Clark JL, Coulibaly S, Mach L. Invasive properties of murine squamous carcinoma cells: secretion of matrix-degrading cathepsins is attributable to a deficiency in the mannose 6-phosphate/insulin-like growth factor II receptor. Cancer Res 2000; 60: 4070-4076.
25. Satz P. Brain reserve capacity on symptom onset after brain injury: a formulation and review of evidence for threshold theory. Neuropsychology 1993; 3: 817-824.
26. Rochefort H, Garcia M, Glondu M, Laurent V, Liaudet E, Rey JM, et al. Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview. Clin Chim Acta 2000; 291: 157-170.
27. DaCosta SA, Schumaker LM, Ellis MJ. Mannose 6-phosphate/insulin-like growth factor 2 receptor, a bona fide tumor suppressor gene or just a promising candidate? J Mammary Gland Biol Neoplasia 2000; 5: 85-94.